Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Serum Institute of India
Pharma
Daiichi Sankyo, Glenmark, Serum-Biocon—Fierce Pharma Asia
Daiichi tripled Enhertu sales in its last fiscal year but had its leukemia drug delayed at the FDA. Glenmark settled an antitrust lawsuit. Plus more.
Angus Liu
Apr 28, 2023 8:35am
Serum Institute doubles its stake in Biocon Biologics to $300M
Apr 25, 2023 9:45am
Serum Insitute ships Novavax shots to US
Jul 15, 2022 12:20pm
Astellas, BeiGene, Serum Institute—Fierce Pharma Asia
Apr 29, 2022 11:22am
Serum Institute worries for 200M unused COVID vaccine doses
Apr 22, 2022 11:21am
Wockhardt, Serum Institute of India to build new UK facility
Mar 21, 2022 10:36am